Paper · 17512414
High-resolution profiling of histone methylations in the human genome.
Barski A and 8 others. Cell, 2007. Cited by 5,287 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. High-resolution profiling of histone methylations in the human genome. Papers, record 17512414. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17512414
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Profiling | Major topic |
| Gene Expression Regulation | Major topic |
| Genome, Human | Major topic |
| Histone-Lysine N-Methyltransferase | Major topic |
| Histones | Major topic |
| Chromatin | |
| Chromosome Breakage | |
| Enhancer Elements, Genetic | |
| Epigenesis, Genetic | |
| Histone Methyltransferases | |
| Humans | |
| Lymphoma | |
| Methylation | |
| Promoter Regions, Genetic | |
| Protein Methyltransferases | |
| RNA Polymerase II | |
| Regulatory Elements, Transcriptional | |
| Transcriptional Activation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Intramural NIH HHS | United States | PubMed | PubMed | ||
| Z01HL005801 | NIH | NIH RePORTER | |||
| ZIAHL005801 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04031716 | Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18,045,524 | ChIP-Seq data reveal nucleosome architecture of human promoters. | https://conductscience.org/library/papers/18045524 |
Source PubMed
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by3,958
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5,287 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,988,903 | Nondisruptive 3D profiling of combinations of epigenetic marks in single cells. | Nat Methods | 2026 | https://conductscience.org/library/papers/42988903 | PubMed |
| 42,981,423 | Genetic dissection of cell type-specific congenital heart disease variants reveals ETS1 control of vascular smooth muscle cell fate. | Sci Adv | 2026 | https://conductscience.org/library/papers/42981423 | PubMed |
| 42,979,755 | Detection and quantification of DNA double-strand breaks by genomic and imaging methods: a critical appraisal of capabilities and limitations. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42979755 | PubMed |
| 42,950,054 | Wdr82-COMPASS coordinates Foxp3 and TCR signaling to sustain Treg cell control of microbiota-driven intestinal inflammation. | Sci Adv | 2026 | https://conductscience.org/library/papers/42950054 | PubMed |
| 42,941,945 | Nanopore Sequencing for Epigenetic Decoding: Applications, Analytical Constraints, and Translational Prospects. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941945 | PubMed |
| 42,940,179 | SOCS3 Suppression Is Associated with Hippocampal Inflammation in a Mouse Model of Intermittent Hypoxia. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940179 | PubMed |
| 42,927,513 | Targeting the epigenetic landscape of ECFCs: a new opportunity to enhance vascular repair. | Angiogenesis | 2026 | https://conductscience.org/library/papers/42927513 | PubMed |
| 42,926,946 | Quantitative gene-level inference of tumor transcription from plasma epigenomes. | Res Sq | 2026 | https://conductscience.org/library/papers/42926946 | PubMed |
| 42,926,749 | Impacts of different SETD1A mutations and genetic backgrounds on human induced pluripotent stem cell-derived hippocampal neurons. | bioRxiv | 2026 | https://conductscience.org/library/papers/42926749 | PubMed |
| 42,895,683 | Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42895683 | PubMed |
1 to 10 of 3,958
See all 3,958 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTCF | 10,664 | PubTator's text mining | https://conductscience.org/library/genes/10664 | NCBI Gene |
| H2AZ1 | 3,015 | PubTator's text mining | https://conductscience.org/library/genes/3015 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17512414
GET https://conductscience.org/api/papers/v1/17512414/cited_by?page=2